Viewing Study NCT04446793


Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2025-12-27 @ 11:45 PM
Study NCT ID: NCT04446793
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2024-02-12
First Post: 2020-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer
Sponsor: Cardiff Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module